New device aims to keep donor hearts healthier for transplant

NCT ID NCT07556588

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early trial tests a device that keeps donor hearts cool and oxygenated during transport, instead of the usual ice cooler. The goal is to see if this method is safe and works for heart transplants from both brain-dead and circulatory-death donors. Twenty adult patients awaiting a heart transplant will take part. If it works, it could lead to better heart preservation and more successful transplants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
XVIVO Heart Assist Transport System (device for hypothermic oxygenated perfusion of donor hearts)
What this could lead to
If successful, this device could help more donor hearts be safely transported and transplanted, potentially increasing the number of heart transplants available.
What could go wrong
This is a very early, small trial with only 20 patients. The device may not improve outcomes or could have unforeseen complications. Results may not apply to all transplant centers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UZ Leuven

    RECRUITING

    Leuven, B-3000, Belgium

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.